Evidence map›Paper›PMID 39976744›Full record

ArticleJournal of clinical immunology2025

Bone Marrow CD8 + Abundance Inversely Correlates with Progressive Marrow Fibrosis and Myelodysplastic Evolution in GATA2 Deficiency: Case Report.

Francesca Vendemini, Samuele Roncareggi, Vincenzo L'Imperio, Fabiola Guerra, Federica Mottadelli, Marco Chiarini, Oscar Maglia, Simona Sala, Grazia Fazio, Rocco Piazza and 3 more

Abstract readCase Reports
In one paragraph

Article in Journal of clinical immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. GATA2 deficiency exacerbates chronic liver injuryWorld journal of stem cells · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Francesca VendeminiPediatria, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Samuele RoncareggiPediatria, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Vincenzo L'ImperioDepartment of Medicine and Surgery, Pathology, IRCCS Fondazione San Gerardo dei Tintori, Monza, Italy.
Fabiola GuerraPediatria, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Federica MottadelliCentro Tettamanti, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Marco ChiariniFlow Cytometry Unit, Clinical Chemistry Laboratory, ASST Spedali Civili Di Brescia, Brescia, Brescia, Italy.
Oscar MagliaCentro Tettamanti, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Simona SalaCentro Tettamanti, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Grazia FazioSchool of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Rocco PiazzaSchool of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Sonia BonanomiPediatria, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Andrea BiondiPediatria, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Francesco SaettiniCentro Tettamanti, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy. f.saettini@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGATA2 deficiency, a rare inborn error of immunity, presents with highly variable phenotypes. Bone marrow (BM) changes such as hypocellularity and myelodysplastic syndrome (MDS) are common, with hematopoietic stem cell transplantation being the only curative option due to the risk of progression to acute myeloid leukemia. Although traditional markers like cytogenetic abnormalities and somatic mutations (e.g., ASXL1) identify the risk of leukemic transformation, efforts to identify novel predictors of disease evolution are needed. CD8+ T cells are known to play a key role in MDS immune surveillance, but their specific involvement in GATA2 deficiency remains poorly defined.

methodsIn this case report, we report on a young adult with GATA2 deficiency who underwent longitudinal monitoring of both peripheral and BM lymphocyte subsets, with a focus on CD8+ T-cell evolution in relation to MDS progression.

resultsThe patient exhibited typical GATA2-deficient immune-hematological findings, including monocytopenia, B- and NK-cell deficiency, but had no history of severe infections and remained transfusion-independent. While peripheral CD8+ T-cell levels remained stable over time, a notable reduction in BM CD8+ T cells was observed in association with MDS progression.

conclusionProviding a long-term follow-up of one GATA2-deficient patient, we suggest that a decrease in BM CD8+ T cells may serve as an early marker of immune surveillance escape and disease progression. These findings underscore the need for further investigation into the role of BM CD8+ T cells in GATA2 deficiency and MDS evolution, potentially offering new insights for follow-up and therapeutic intervention.

Indexed as

Bone MarrowCD8-Positive T-LymphocytesGATA2 DeficiencyGATA2 Transcription FactorMyelodysplastic SyndromesAdolescentDisease ProgressionFemaleHumansGATA2 protein, humanGATA2 Transcription FactorGATA2 deficiencyMyelodysplastic syndromeMyelofibrosisT Lymphocytes

Identifiers

PMID39976744
PMCPMC11842526

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.